Alcoholic Hepatitis Clinical and Translational Network – Basic and Pre-Clinical Research (UH2/UH3)

Funding Agency:
National Institutes of Health

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on “Translational Research in Alcoholic Hepatitis” to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into “AH Clinical and Translational Network”, hereafter termed “AH Network”. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component.

Through this FOA, applications are sought to conduct basic and pre-clinical studies addressing high impact areas in Alcoholic Hepatitis under the UH2/UH3 Phase Innovation Awards Cooperative Agreement funding mechanism.

Companion FOAs:

RFA-AA-18-002U01 Research Project – Cooperative Agreements

RFA-AA-18-003U01 Research Project – Cooperative Agreements

RFA-AA-18-004U24 Resource-Related Research Projects – Cooperative Agreements

RFA-AA-18-005U01 Research Project – Cooperative Agreements

Deadlines:

  • Letter of Intent Due Date(s): September 23, 2017
  • Application Due Date(s): October 23, 2017

RFA-AA-18-006 Expiration Date October 24, 2017

Agency Website

Amount Description

Applicants may request up to $275,000 direct costs for the entire UH2 phase with no more than $200,000 direct costs for any year of the UH2 phase. Applicants may request up to $250,000 direct costs for the UH3 phase per year. Budget should reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period. In the UH2 phase, the maximum project period is 2 years, and in UH3 phase, the maximum project period is 3 years for a total of 5 years.

Funding Type

Grant

Eligibility

Faculty
Institutional

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 23, 2017